glp-1 sales Waistlines and GLP-1s—Expanding in Unison Exploring the Growth of GLP-1

These issues intersect with pharma economics: drug companies will point to downstream cost savings, while payers will demand hard data

Fortunately, we were already positioned well before GLP-1s became a mainstream topic, says Dritsas

The current study and approach has several limitations

GLP-1 users gravitate toward fruits, lean proteins, and plant-based options while running from anything fatty, sticky, or dense enough to double as construction material

Glucagon receptor activation appears counterintuitive in obesity and diabetes therapy because glucagon acutely increases hepatic glucose output

The cellular and functional complexity of thermogenic fat